Austin Gurney, See Remarks at OncoMed Pharmaceuticals Inc (OMED), sold 14,000 shares at $20.68 ($292K) on 2015-07-29, disclosed to the SEC on 2015-07-31.
Scheduled sale ($292k) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.68 | 7,000 | $145K | 49.5% |
| 2 | $21.01 | 5,901 | $124K | 42.4% |
| 3 | $21.47 | 1,099 | $24K | 8.1% |
| Total | $20.88 avg | 14,000 | $292K | 100% |
| Filing → |
| OMED | SELL | 2018-10-10 | $4K | — | Filing → |
| OMED | SELL | 2018-04-26 | $11K | — | Filing → |
| OMED | SELL | 2017-10-12 | $5K | — | Filing → |